Trifluoroacetic acid → HCID 58382044, compound
Reaction equation
[P:1]([O:13][CH2:14][N:15]1[C:19]2[N:20]=[CH:21][C:22]3[N:23]([C:24]([CH3:27])=[N:25][CH:26]=3)[C:18]=2[CH:17]=[C:16]1[C:28]1[C:36]2[C:31](=[CH:32][CH:33]=[C:34]([O:37][CH3:38])[CH:35]=2)[N:30]([CH3:39])[CH:29]=1)([O:8]C(C)(C)C)([O:3]C(C)(C)C)=[O:2].C(O)(C(F)(F)F)=O>C(Cl)Cl>[P:1]([OH:3])([OH:8])([O:13][CH2:14][N:15]1[C:19]2[N:20]=[CH:21][C:22]3[N:23]([C:24]([CH3:27])=[N:25][CH:26]=3)[C:18]=2[CH:17]=[C:16]1[C:28]1[C:36]2[C:31](=[CH:32][CH:33]=[C:34]([O:37][CH3:38])[CH:35]=2)[N:30]([CH3:39])[CH:29]=1)=[O:2]Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
Di-tert-butyl (7-(5-methoxy-1-methyl-1H-indol-3-yl)-1-methyl-6H-imidazo[1,5-a]pyrrolo[2,3-e]pyrazin-6-yl)methyl phosphate (0.2 g, 0.361 mmol) was dissolved in DCM (5 mL) then TFA (0.2 mL, 2.60 mmol) was added. After about 20 min at rt the reaction mixture was concentrated under reduced pressure. The material was dissolved in DMF (7.5 mL) then the material was purified by preparative reverse phase HPLC (Table 2, Method i). The fractions were collected and concentrated under reduced pressure to remove most or all of the MeCN. The solid was collected by filtration and dried under vacuum to a constant weight at about 60° C. to provide (7-(5-methoxy-1-methyl-1H-indol-3-yl)-1-methyl-6H-imidazo[1,5-a]pyrrolo[2,3-e]pyrazin-6-yl)methyl dihydrogen phosphate (0.065 g, 41%): LC/MS (Table 2, Method a) Rt=1.42 min; MS m/z 442 (M+H)+.
Workup
- concentrationAfter about 20 min at rt the reaction mixture was concentrated under reduced pressure
- dissolutionThe material was dissolved in DMF (7.5 mL)
- customthe material was purified by preparative reverse phase HPLC (Table 2, Method i)
- customThe fractions were collected
- concentrationconcentrated under reduced pressure
- customto remove most
- filtrationThe solid was collected by filtration
- customdried under vacuum to a constant weight at about 60° C.
Sources & evidence
- ORD record
- ord-2b7421d472da46d3a1cec5eb2e2f3c2c
- Source dataset
- uspto-grants-2014_07
- Patent number
- US08785639B2
Reaction notes
Loading…